Skip to content
About Us
Oncolytic Viruses
Immunotherapy Combinations
R&D Facility
Team
Company News
Corporate Investor Deck
Our Technology
IVX037
IVX055
Pipeline
Scientific Presentations
Pre-clinical / discovery
Clinical
Therapeutic Strategy
Innovent Collaboration
Pipeline
Leadership Team
Board
Management Team
Investor Centre
Corporate Deck
Company Announcements
In the News
ESG
Recruitment
Contact Us
About Us
Oncolytic Viruses
Immunotherapy Combinations
R&D Facility
Team
Company News
Corporate Investor Deck
Our Technology
IVX037
IVX055
Pipeline
Scientific Presentations
Pre-clinical / discovery
Clinical
Therapeutic Strategy
Innovent Collaboration
Pipeline
Leadership Team
Board
Management Team
Investor Centre
Corporate Deck
Company Announcements
In the News
ESG
Recruitment
Contact Us
Day:
June 6, 2023
Cancer-fighting biotech ImmVirX secures $15m from OneVentures
You can read the full story here.
